EGL Acquisition

EGL Genetics, formerly known as Emory Genetics Laboratory, is a leading clinical diagnostic laboratory specializing in comprehensive genetic testing services. Founded at Emory University, the company provides a wide range of diagnostic solutions, including next-generation sequencing, biochemical genetics, and cytogenetics, to identify rare genetic and metabolic disorders. EGL Genetics is recognized for its expertise in complex clinical cases and its extensive menu of specialized tests for both pediatric and adult patients. The company was acquired by Eurofins Scientific in a phased transaction between 2015 and 2017 and now operates as a key component of Eurofins' clinical diagnostics network.